Citryll is a Biotech company based in Oss, Netherlands. It has raised $128M in total funding. Latest round: Series B.
Citryll is a Biotech company based in Oss, Netherlands. Citryll has raised $128M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for Citryll runs through 2024; nothing later has been disclosed. Investors on record include Johnson & Johnson Innovation - JJDC, Inc., Forbion, Novartis Venture Fund, Pureos Bioventures, BioGeneration Ventures, Seventure Partners and 2 others. 8 distinct backers are named across the disclosed rounds.
Round data for Citryll is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Oss and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026